Eli Lilly Stock Outlook: Is Wall Street Bullish or Bearish?

Founded in 1876, Indianapolis, Indiana-based Eli Lilly and Company (LLY) discovers, develops, and markets human pharmaceuticals in the United States and internationally. The company has a market capitalization of $980.5 billion and boasts a diversified product profile, including a solid lineup of new, successful drugs.

Shares of the healthcare giant have outperformed the broader market over the past year, but have underperformed in 2026. LLY stock has grown 28.7% over the past 52 weeks and has declined 2.8% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 15.5% over the past year and risen 1.9% in 2026.